# Capella BioScience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/capella-bioscience

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.capellabioscience.com
- Total disclosed funding: $15M
- Latest round: Series A (Mar 4, 2016)
- Investors on record: 3

## About

Capella BioScience is based in London, UK and was founded in 2014. The firm develops novel medicines based on monoclonal antibodies (mAbs) to the next generation of important therapeutic targets in oncology and autoimmune disease.

## Funding rounds

- Series A, Mar 4, 2016, $15M — OUP (Osage University Partners), Medicxi, Advent Life Sciences

## Investors

- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series A
- Medicxi (https://capitalatlas.ai/funds/medicxi) — Series A
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series A